Daktari Diagnostics achieved another milestone in its quest to raise $30 million for its groundbreaking HIV test. The company recently brought in $13 million in equity, moving it closer to realizing ...
Daktari Diagnostics is well underway with plans to raise between $25 million and $30 million in Series D financing, money that co-founder and CEO Bill Rodriguez said will help, in part, to expand ...
Merck & Co. will partner with Daktari Diagnostics to develop Daktari’s rapid hepatitis C virus (HCV) screening test, under a collaboration that will generate up to $8.5 million over three years for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results